eGenesis Announces World’s First Successful Transplant of Genetically Engineered Pig Kidney in a Living Patient

- Marks historic milestone and opens new frontier in transplantation to address kidney shortage affecting millions of patients globally

- Transplant was conducted at Massachusetts General Hospital and authorized by the U.S. FDA under a single Expanded Access protocol

On March 21, 2024, eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, announced the first-ever transplantation of a genetically engineered porcine kidney into a living human recipient. The transplant was authorized by the U.S. Food & Drug Administration (FDA) under the Expanded Access pathway and performed by a surgical team at Massachusetts General Hospital (MGH) led by Tatsuo Kawai, MD, PhD and Nahel Elias, MD. The patient suffers from end-stage renal disease and lacked other therapeutic options following the loss of vascular access to support continued use of dialysis. Following the procedure, the patient is in good condition and recovering well at MGH.

Login Or Register To Read Full Story